In patients with HF with reduced ejection fraction (HFrEF) following an acute MI, clinical studies revealed that treatment with statins, such as Atorvastatin, Rosuvastatin, and Pravastatin, led to reduced serum MMP-2 levels, which were accompanied by lower mortality rates and fewer hospital readmissions [41]. The gene discussed is MMP2; the disease is hydrops fetalis.